Seaview Investment Managers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Seaview Investment Managers's PFE Position: Q3 2022 in Review
Seaview Investment Managers sold out of Pfizer (PFE) in Q3 2022, closing a stake of 7,056 shares — an estimated $370K sold.
Seaview Investment Managers first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $9.31M in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Seaview Investment Managers reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
- Seaview Investment Managers sold 7,056 Pfizer shares in Q3 2022, an estimated $370K.
- Seaview Investment Managers first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
- Seaview Investment Managers's Pfizer position peaked at $9.31M in Q4 2021.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Seaview Investment Managers's 13F filing for Q3 2022, filed 10 Nov 2022.